Additional targets of miR-155-5p include HSD17B12, MYC, SMAD1, SMAD3 and p53-inducible nuclear protein 1 (TP53INP1) all of which are downregulated, contributing to tumor advancement [133,134,135]. Here, TP53INP1 is linked to neoplasm.